Rheumatoid anemia

Area of Science:

• Hematology
• Immunology
• Rheumatology

Background:

• Rheumatoid anemia is a common anemia of chronic disease, distinct from iron deficiency anemia.
• It presents as normochromic, normocytic (or microcytic), aregenerative anemia with thrombocytosis.
• Key diagnostic features include normal/low transferrin saturation, normal/high ferritin, and normal soluble transferrin receptor (sTfR).

Purpose of the Study:

• To review the prevalence and impact of rheumatoid anemia.
• To describe iron metabolism in the context of rheumatoid anemia.
• To highlight the roles of hepcidin and interleukin-6 (IL-6) in its pathogenesis.

Main Methods:

• Literature review of studies on rheumatoid anemia, iron metabolism, transferrin, ferritin, and hepcidin.
• Analysis of data linking IL-6 to anemia development in chronic disease.
• Review of recent data on hepcidin levels in rheumatoid arthritis patients.

Main Results:

• Hepcidin, regulated by IL-6 and hemojuvelin, is central to rheumatoid anemia pathogenesis.
• IL-6 increases hepcidin production, leading to reduced serum iron and impaired erythropoiesis.
• Iron deficiency and increased erythropoiesis suppress hepcidin production.

Conclusions:

• Rheumatoid anemia pathogenesis involves a cascade of IL-6, hepcidin, and iron dysregulation.
• Optimal control of rheumatoid arthritis disease activity is crucial for managing rheumatoid anemia.
• IL-6 antagonists represent a promising therapeutic strategy for rheumatoid anemia.